Dogwood Wealth Management’s Oncolytics Biotech ONCY Stock Holding History

Dogwood Wealth Management’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$139	Hold	146	–	–	﹤0.01%	833
2026 Q1	$124	Hold	146	–	–	﹤0.01%	832
2025 Q4	$128	Hold	146	–	–	﹤0.01%	704
2025 Q3	$204	Hold	146	–	–	﹤0.01%	690
2025 Q2	$182	Hold	146	–	–	﹤0.01%	668
2025 Q1	$80	Hold	146	–	–	﹤0.01%	520
2024 Q4	$133	Buy	+146	New	+$152	﹤0.01%	265

Other funds holding ONCY

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return

BPWM

Badgley Phelps Wealth Managers Seattle, Washington $5.71B AUM 30.33% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PAS

Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Dogwood Wealth Management's ONCY Position: Q2 2026 in Review

Dogwood Wealth Management held its Oncolytics Biotech (ONCY) position steady in Q2 2026 at 146 shares worth $139. The position accounts for ﹤0.01% of the portfolio, ranked #833.

Dogwood Wealth Management first reported a position in ONCY in Q4 2024 and has held it in 7 quarters since. The position peaked at $204 in Q3 2025. 24 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

Dogwood Wealth Management held 146 shares of Oncolytics Biotech worth $139 as of Q2 2026.
Dogwood Wealth Management left its Oncolytics Biotech share count unchanged in Q2 2026.
Oncolytics Biotech made up ﹤0.01% of Dogwood Wealth Management's portfolio in Q2 2026, its #833 holding.
Dogwood Wealth Management first reported a position in Oncolytics Biotech in Q4 2024 and has held it in 7 quarters since.
Dogwood Wealth Management's Oncolytics Biotech position peaked at $204 in Q3 2025.
24 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Dogwood Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.